LTAS
RMD icon

Linden Thomas Advisory Services’s ResMed RMD Stock Holding History

Linden Thomas Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56M Sell
33,667
-630
-2% -$131K 0.53% 28
2026
Q1 		$7.7M Buy
34,297
+1,137
+3% +$283K 0.74% 8
2025
Q4 		$7.99M Buy
33,160
+25
+0.1% +$6.39K 0.81% 12
2025
Q3 		$9.07M Buy
33,135
+612
+2% +$167K 0.92% 10
2025
Q2 		$8.39M Buy
32,523
+16,631
+105% +$3.97M 0.92% 7
2025
Q1 		$3.56M Buy
15,892
+515
+3% +$120K 0.46% 44
2024
Q4 		$3.52M Buy
15,377
+462
+3% +$111K 0.45% 46
2024
Q3 		$3.64M Buy
14,915
+195
+1% +$43.6K 0.5% 35
2024
Q2 		$2.82M Buy
14,720
+8,070
+121% +$1.64M 0.44% 47
2024
Q1 		$1.32M Buy
6,650
+160
+2% +$29.3K 0.21% 201
2023
Q4 		$1.12M Buy
6,490
+105
+2% +$16.1K 0.21% 215
2023
Q3 		$944K Sell
6,385
-3,332
-34% -$602K 0.21% 206
2023
Q2 		$2.12M Buy
9,717
+320
+3% +$71.3K 0.47% 41
2023
Q1 		$2.06M Buy
9,397
+169
+2% +$36.7K 0.51% 40
2022
Q4 		$1.92M Buy
+9,228
New +$2.03M 0.54% 34

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Linden Thomas Advisory Services's RMD Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its ResMed (RMD) stake by 1.8% in Q2 2026, selling an estimated $131K and leaving 33,667 shares worth $6.56M. The position accounts for 0.53% of the portfolio, ranked #28.

Linden Thomas Advisory Services first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.07M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Linden Thomas Advisory Services held 33,667 shares of ResMed worth $6.56M as of Q2 2026.
  • Linden Thomas Advisory Services sold 630 ResMed shares in Q2 2026, an estimated $131K.
  • ResMed made up 0.53% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #28 holding.
  • Linden Thomas Advisory Services first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's ResMed position peaked at $9.07M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.